Pathologists

We enhance your expertise by empowering the highly accurate detection of complex biomarkers in a streamlined workflow.

Maximizing insights from molecular data

Each cancer type has a unique pattern of biomarkers which can be complex to assess. As a pathologist, oncologists rely on you to identify actionable insights from
tumor profiling data and to help inform decisions. With the biomarker landscape constantly evolving, keeping pace while providing precise information is increasingly demanding.

Our mission is to streamline the analysis of complex data, providing access to sophisticated technologies and the latest evidence to help you quickly and accurately detect even the most challenging biomarkers.

Ensure accurate results

Leverage trusted analytics for precise molecular tumor profiling.

Streamline interpretation

Assess co-occurring molecular biomarkers, all in one place.

Improve workflow efficiency

Easily integrate our platform within your laboratory setting.

Enhance genomic analysis with SOPHiA DDM™

Expedite insights from NGS data

SOPHiA DDM™ for Genomics uses advanced AI algorithms to accurately detect, annotate, and pre-classify genomic variants from complex and noisy cancer molecular profiling data. The platform provides automatic variant calling and diverse filtering functionality for more confident, faster decision-making in your daily workflows.

SOPHiA DDM™ for Genomics

OncoPortal™ and Reporting

Utilize the latest manually-curated scientific evidence to quickly and confidently interpret tumor molecular profiles and generate customizable reports.

Learn More

Featured Resources

Webinar

The Andalusian Health Service address a colorectal cancer case with the CE IVD-marked SOPHiA DDM^TM Dx Hereditary Cancer Solution

Decoding complexity: Tackling real-world challenges in variant analysis – Overcoming noise in precision variant analysis

RESOURCE

A Universal Library Prep for all SOPHiA DDM™ Solutions

Featured Resources

Webinar

Going beyond HRR mutations:
A deep-learning approach on HRD detection in ovarian cancer

Case Study

Unlocking access to MSK-ACCESS® for robust liquid biopsy analysis

Customer Spotlight

Customer Spotlight: Dr. Elena Repetti - TomaLab Advanced Biomedical Assays

Blog

Liquid biopsy analysis: Screening for clinically relevant information

Webinar

The importance of of biomarker analysis in Chronic Lymphoblastic Leukemia

SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise.

SOPHiA DDM™ Dx Hereditary Cancer Solution, SOPHiA DDM™ Dx RNAtarget Oncology Solution and SOPHiA DDM™ Dx Homologous Recombination Deficiency Solution are available as CE-IVD products for In Vitro Diagnostic Use in the European Economic Area (EEA), the United Kingdom and Switzerland. SOPHiA DDM™ Dx Myeloid Solution and SOPHiA DDM™ Dx Solid Tumor Solution are available as CE-IVD products for In Vitro Diagnostic Use in the EEA, the United Kingdom, Switzerland, and Israel. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us at support@sophiagenetics.com to obtain the appropriate product information for your country of residence.

All third-party trademarks listed by SOPHiA GENETICS remain the property of their respective owners. Unless specifically identified as such, SOPHiA GENETICS’ use of third-party trademarks does not indicate any relationship, sponsorship, or endorsement between SOPHiA GENETICS and the owners of these trademarks. Any references by SOPHiA GENETICS to third-party trademarks is to identify the corresponding third-party goods and/or services and shall be considered nominative fair use under the trademark law.

SOPHiA DDM™ Overview

SOPHiA DDM™ for Genomics

SOPHiA DDM™ for Radiomics

SOPHiA DDM™ for Multimodal

Professional Services